Suppr超能文献

2002年美国国立精神卫生研究所阿尔茨海默病抑郁临时诊断标准(PDC-dAD):十年后对其有效性的评估

The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.

作者信息

Sepehry Amir A, Lee Philip E, Hsiung Ging-Yuek R, Beattie B Lynn, Feldman Howard H, Jacova Claudia

机构信息

University of British Columbia (UBC), College for Interdisciplinary Studies, Graduate program in Neuroscience, Vancouver, Canada.

Department of Medicine, UBC Division of Neurology, Vancouver, Canada.

出版信息

J Alzheimers Dis. 2017;58(2):449-462. doi: 10.3233/JAD-161061.

Abstract

Presented herein is evidence for criterion, content, and convergent/discriminant validity of the NIMH-Provisional Diagnostic Criteria for depression of Alzheimer's Disease (PDC-dAD) that were formulated to address depression in Alzheimer's disease (AD). Using meta-analytic and systematic review methods, we examined criterion validity evidence in epidemiological and clinical studies comparing the PDC-dAD to Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV), and International Classification of Disease (ICD 9) depression diagnostic criteria. We estimated prevalence of depression by PDC, DSM, and ICD with an omnibus event rate effect-size. We also examined diagnostic agreement between PDC and DSM. To gauge content validity, we reviewed rates of symptom endorsement for each diagnostic approach. Finally, we examined the PDC's relationship with assessment scales (global cognition, neuropsychiatric, and depression definition) for convergent validity evidence. The aggregate evidence supports the validity of the PDC-dAD. Our findings suggest that depression in AD differs from other depressive disorders including Major Depressive Disorder (MDD) in that dAD is more prevalent, with generally a milder presentation and with unique features not captured by the DSM. Although the PDC are the current standard for diagnosis of depression in AD, we identified the need for their further optimization based on predictive validity evidence.

摘要

本文展示了美国国立精神卫生研究所(NIMH)制定的用于解决阿尔茨海默病(AD)中抑郁症问题的阿尔茨海默病抑郁症临时诊断标准(PDC-dAD)的标准效度、内容效度以及聚合效度/区分效度的证据。我们采用荟萃分析和系统评价方法,在流行病学和临床研究中检验标准效度证据,将PDC-dAD与《精神疾病诊断与统计手册》第四版(DSM-IV)以及《国际疾病分类》(ICD-9)抑郁症诊断标准进行比较。我们用综合事件率效应量估计了PDC、DSM和ICD诊断的抑郁症患病率。我们还检验了PDC与DSM之间的诊断一致性。为评估内容效度,我们审查了每种诊断方法的症状认可率。最后,为获取聚合效度证据,我们检验了PDC与评估量表(整体认知、神经精神和抑郁症定义)之间的关系。总体证据支持PDC-dAD的效度。我们的研究结果表明,AD中的抑郁症与其他抑郁症不同,包括重度抑郁症(MDD),因为AD中的抑郁症患病率更高,通常表现较轻,且具有DSM未涵盖的独特特征。尽管PDC是目前AD中抑郁症诊断的标准,但我们基于预测效度证据确定了对其进一步优化的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验